221 related articles for article (PubMed ID: 14965318)
1. Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease.
Verdier Y; Penke B
Curr Protein Pept Sci; 2004 Feb; 5(1):19-31. PubMed ID: 14965318
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease.
Verdier Y; Zarándi M; Penke B
J Pept Sci; 2004 May; 10(5):229-48. PubMed ID: 15160835
[TBL] [Abstract][Full Text] [Related]
3. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.
Bamberger ME; Harris ME; McDonald DR; Husemann J; Landreth GE
J Neurosci; 2003 Apr; 23(7):2665-74. PubMed ID: 12684452
[TBL] [Abstract][Full Text] [Related]
4. Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid.
Alarcón R; Fuenzalida C; Santibáñez M; von Bernhardi R
J Biol Chem; 2005 Aug; 280(34):30406-15. PubMed ID: 15987691
[TBL] [Abstract][Full Text] [Related]
5. Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE)--and amyloid beta 1-42-induced signal transduction in glial cells.
Slowik A; Merres J; Elfgen A; Jansen S; Mohr F; Wruck CJ; Pufe T; Brandenburg LO
Mol Neurodegener; 2012 Nov; 7():55. PubMed ID: 23164356
[TBL] [Abstract][Full Text] [Related]
6. Structural and mechanistic commonalities of amyloid-β and the prion protein.
Da Costa Dias B; Jovanovic K; Gonsalves D; Weiss SF
Prion; 2011; 5(3):126-37. PubMed ID: 21862871
[TBL] [Abstract][Full Text] [Related]
7. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils.
Coraci IS; Husemann J; Berman JW; Hulette C; Dufour JH; Campanella GK; Luster AD; Silverstein SC; El-Khoury JB
Am J Pathol; 2002 Jan; 160(1):101-12. PubMed ID: 11786404
[TBL] [Abstract][Full Text] [Related]
8. Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer.
Mackic JB; Stins M; McComb JG; Calero M; Ghiso J; Kim KS; Yan SD; Stern D; Schmidt AM; Frangione B; Zlokovic BV
J Clin Invest; 1998 Aug; 102(4):734-43. PubMed ID: 9710442
[TBL] [Abstract][Full Text] [Related]
9. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology.
Wang HY; Lee DH; D'Andrea MR; Peterson PA; Shank RP; Reitz AB
J Biol Chem; 2000 Feb; 275(8):5626-32. PubMed ID: 10681545
[TBL] [Abstract][Full Text] [Related]
10. Microglial Aβ receptors in Alzheimer's disease.
Yu Y; Ye RD
Cell Mol Neurobiol; 2015 Jan; 35(1):71-83. PubMed ID: 25149075
[TBL] [Abstract][Full Text] [Related]
11. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.
Cho HJ; Son SM; Jin SM; Hong HS; Shin DH; Kim SJ; Huh K; Mook-Jung I
FASEB J; 2009 Aug; 23(8):2639-49. PubMed ID: 19332646
[TBL] [Abstract][Full Text] [Related]
12. Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists.
Bi X; Gall CM; Zhou J; Lynch G
Neuroscience; 2002; 112(4):827-40. PubMed ID: 12088742
[TBL] [Abstract][Full Text] [Related]
13. Microglia demonstrate age-dependent interaction with amyloid-β fibrils.
Floden AM; Combs CK
J Alzheimers Dis; 2011; 25(2):279-93. PubMed ID: 21403390
[TBL] [Abstract][Full Text] [Related]
14. Effects of Low Amyloid-β (Aβ) Concentration on Aβ1-42 Oligomers Binding and GluN2B Membrane Expression.
Gilson V; Mbebi-Liegeois C; Sellal F; de Barry J
J Alzheimers Dis; 2015; 47(2):453-66. PubMed ID: 26401567
[TBL] [Abstract][Full Text] [Related]
15. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
Lue LF; Yan SD; Stern DM; Walker DG
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
[TBL] [Abstract][Full Text] [Related]
16. IL-4-induced selective clearance of oligomeric beta-amyloid peptide(1-42) by rat primary type 2 microglia.
Shimizu E; Kawahara K; Kajizono M; Sawada M; Nakayama H
J Immunol; 2008 Nov; 181(9):6503-13. PubMed ID: 18941241
[TBL] [Abstract][Full Text] [Related]
17. A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid β peptide-mediated neuronal disorder.
Cai C; Dai X; Zhu Y; Lian M; Xiao F; Dong F; Zhang Q; Huang Y; Zheng Q
Appl Microbiol Biotechnol; 2016 Jan; 100(2):825-35. PubMed ID: 26496918
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease.
Leclerc E; Sturchler E; Vetter SW; Heizmann CW
Rev Neurosci; 2009; 20(2):95-110. PubMed ID: 19774788
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q.
Webster SD; Galvan MD; Ferran E; Garzon-Rodriguez W; Glabe CG; Tenner AJ
J Immunol; 2001 Jun; 166(12):7496-503. PubMed ID: 11390503
[TBL] [Abstract][Full Text] [Related]
20. Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity.
Sturchler E; Galichet A; Weibel M; Leclerc E; Heizmann CW
J Neurosci; 2008 May; 28(20):5149-58. PubMed ID: 18480271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
